SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001437749-20-006155
Filing Date
2020-03-26
Accepted
2020-03-26 08:11:24
Documents
67
Period of Report
2019-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K atos20191231_10k.htm 10-K 1135717
2 EXHIBIT 4.16 ex_178782.htm EX-4.16 20296
3 EXHIBIT 22.1 ex_167063.htm EX-22.1 1325
4 EXHIBIT 23.1 ex_167064.htm EX-23.1 3939
5 EXHIBIT 31.1 ex_167065.htm EX-31.1 12475
6 EXHIBIT 31.2 ex_167066.htm EX-31.2 12099
7 EXHIBIT 32.1 ex_167067.htm EX-32.1 6357
8 EXHIBIT 32.2 ex_167068.htm EX-32.2 6475
  Complete submission text file 0001437749-20-006155.txt   4879972

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT atos-20191231.xml EX-101.INS 801897
10 XBRL TAXONOMY EXTENSION SCHEMA atos-20191231.xsd EX-101.SCH 51882
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE atos-20191231_cal.xml EX-101.CAL 40972
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE atos-20191231_def.xml EX-101.DEF 351539
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE atos-20191231_lab.xml EX-101.LAB 332906
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atos-20191231_pre.xml EX-101.PRE 380356
Mailing Address 107 SPRING STREET SEATTLE WA 98104
Business Address 107 SPRING STREET SEATTLE WA 98104 206.588.0256
ATOSSA THERAPEUTICS, INC. (Filer) CIK: 0001488039 (see all company filings)

IRS No.: 264753208 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-35610 | Film No.: 20744241
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences